Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Prothena Corporation plc (NASDAQ: PRTA) closed at $6.87 in the last session, down -0.15% from day before closing price of $6.88. In other words, the price has decreased by -$0.15 from its previous closing price. On the day, 0.99 million shares were traded. PRTA stock price reached its highest trading level at $7.225 during the session, while it also had its lowest trading level at $6.83.
Ratios:
We take a closer look at PRTA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.00 and its Current Ratio is at 9.00. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Jefferies Downgraded its Buy to Hold on May 27, 2025, while the target price for the stock was maintained at $6.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 02 ’25 when EcoR1 Capital, LLC sold 3,317,938 shares for $8.36 per share. The transaction valued at 27,744,929 led to the insider holds 8,266,342 shares of the business.
EcoR1 Capital, LLC sold 1,984,053 shares of PRTA for $15,164,712 on May 06 ’25. The 10% Owner now owns 5,304,596 shares after completing the transaction at $7.64 per share. On May 05 ’25, another insider, EcoR1 Capital, LLC, who serves as the 10% Owner of the company, sold 977,693 shares for $8.11 each. As a result, the insider received 7,930,166 and left with 7,288,649 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRTA now has a Market Capitalization of 369791488 and an Enterprise Value of -37940632. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.68 while its Price-to-Book (P/B) ratio in mrq is 0.84. Its current Enterprise Value per Revenue stands at -0.275 whereas that against EBITDA is 0.276.
Stock Price History:
The Beta on a monthly basis for PRTA is -0.03, which has changed by -0.67517734 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, PRTA has reached a high of $24.10, while it has fallen to a 52-week low of $4.32. The 50-Day Moving Average of the stock is 14.82%, while the 200-Day Moving Average is calculated to be -41.11%.
Shares Statistics:
According to the various share statistics, PRTA traded on average about 1.81M shares per day over the past 3-months and 836990 shares per day over the past 10 days. A total of 53.83M shares are outstanding, with a floating share count of 42.32M. Insiders hold about 21.38% of the company’s shares, while institutions hold 70.55% stake in the company. Shares short for PRTA as of 1752537600 were 4757454 with a Short Ratio of 2.63, compared to 1749772800 on 4655763. Therefore, it implies a Short% of Shares Outstanding of 4757454 and a Short% of Float of 16.63.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 3.0 analysts currently analyzing and rating the stock of Prothena Corporation plc (PRTA).The consensus estimate for the next quarter is -$0.88, with high estimates of -$0.49 and low estimates of -$1.13.
Analysts are recommending an EPS of between -$4.49 and -$4.58 for the fiscal current year, implying an average EPS of -$4.54. EPS for the following year is -$2.34, with 8.0 analysts recommending between -$0.43 and -$4.63.
